Skip to content

Ketoprofen Gel vs Placebo in Children With Ankle Sprain

Ketoprofen Gel vs Placebo in Children Presented With Ankle Sprain to the Emergency Department: A Randomised Controlled Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02491736
Enrollment
100
Registered
2015-07-08
Start date
2015-06-30
Completion date
2016-01-31
Last updated
2015-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Sprain

Brief summary

The aim of this study is to analyse the effect of ketoprofen gel in children presented with ankle sprain to the emergency department.

Detailed description

Ankle sprains may be associated with soft tissue injuries and fractures. Although diagnostic modalities are important, alleviation of pain is also a part of emergency department management. The aim of this study is to analyse the effect of ketoprofen gel in children presented with ankle sprain to the emergency department.

Interventions

DRUGKetoprofen

2.5% ketoprofen gel

OTHERPlacebo

Placebo gel

Sponsors

Akdeniz University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Patients with ankle sprain * Patients over 8 and lower than 18 years old

Exclusion criteria

* Ankle sprain more than 24 hours * visual analogue scale score lower than 40mm * Allergy to the study drug

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue Scale30 minutesMeasurement of pain reduce at 30 minutes by visual analogue scale

Secondary

MeasureTime frame
Adverse effects30 minutes

Countries

Turkey (Türkiye)

Contacts

Primary ContactAysel Özkan
karek@pau.edu.tr00902582961758

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026